State study finds cannabis eases cancer symptoms
A Minnesota state study found cancer patients in the state medical cannabis program reported relief from nausea, vomiting, appetite loss, anxiety, depression and pain after starting cannabis.[1]
Within four months of their first purchase, 47.2% of patients with moderate to severe vomiting reported improvement.[1] About 40% of patients with nausea and 38.2% with lack of appetite also reported improvement.[1] Around 40% of patients with moderate to severe anxiety, 44% with depression and roughly 30% with pain said their symptoms eased in the same window.[1]
The study analyzed records from 6,621 Minnesota cancer patients enrolled in the state medical cannabis program from July 1, 2015, to Dec. 31, 2023.[1] Minnesota's medical cannabis program now has more than 90,000 registered patients, and enrollment doubled after program fees were eliminated in 2023 and qualifying conditions were expanded in 2024.[1]
Show source details & analysis (1 source)
📌 Key Facts
- OCM study analyzed data from 6,621 Minnesota cancer patients enrolled in the state medical cannabis program from July 1, 2015 to Dec. 31, 2023.
- Within four months of first purchase, 47.2% of patients with moderate to severe vomiting, about 40% with nausea, and 38.2% with lack of appetite reported improvement.
- Around 40% of patients with moderate to severe anxiety, 44% with depression, and roughly 30% with pain reported symptom relief in the same window.
- Minnesota’s medical cannabis program now has more than 90,000 registered patients, with enrollment doubling after fees were eliminated in 2023 and qualifying conditions expanded in 2024.
📰 Source Timeline (1)
Follow how coverage of this story developed over time